Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

vs.MS

US doctors supportive of patients who track their health

But Manhattan Research study finds measurements used remain low-tech

- PMLiVE

AstraZeneca supports NHS medication passport app

Backs NIHR-NHS initiative under joint working agreement

Pharma digital spending up 40 per cent

But overall marketing investments saw no increase in 2012

- PMLiVE

From marketing to medical: Pharma’s informational source shift

The changing role of medical information in HCP communications pathways

ABPI publishes updated guidance on pharmacovigilance and digital media

In a guest blog, the ABPI's Esteban Herrero-Martinez explains what changes to European pharmacovigilance legislation mean for ABPI members

Biogen Idec building

Biogen Idec’s Tecfidera approved in US

Green light from FDA closely follows MS drug's European approval

- PMLiVE

Look who’s talking (2.0): How technology is shaping healthcare communications

Despite rhetoric to the contrary, the healthcare conversation has not changed - it’s only just started. Is technology helping to shift the dynamics of healthcare communications?

- PMLiVE

CHMP backs oral MS drugs from Sanofi, Biogen Idec

Tecfidera and Aubagio recommended for use in Europe

Sanofi reception

Follow-up data suggests long-term benefit of Sanofi’s Lemtrada in MS

Drug has a durable effect on relapse rates and disability progression

Biogen Idec building

Biogen wins extra patent protection for MS drug Tecfidera

Dosing patent provides exclusivity until 2028

- PMLiVE

GW Pharma says German Sativex pricing “unacceptable”

May pull MS drug from market

China: Engagement strategies

As China grows apace, digital is increasingly being used to engage both customers and patients

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links